ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

XLO Xilio Therapeutics Inc

1,18
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:16:45
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Xilio Therapeutics Inc XLO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 1,18 10:16:45
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,18
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.4.202422:05GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
28.3.202412:05GLOBEXilio Therapeutics Announces $11.3 Million Private Placement..
28.3.202412:00BWGilead and Xilio Announce Exclusive License Agreement for..
28.2.202422:01GLOBEXilio Therapeutics to Participate in Novel Immuno-Oncology..
31.1.202422:01GLOBEXilio Therapeutics to Present at Guggenheim 6th Annual..
19.1.202422:30EDGAR2Form 8-K - Current report
08.1.202413:30GLOBEXilio Therapeutics Highlights Recent Advances Across..
03.1.202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:05EDGAR2Form 8-K - Current report
07.12.202313:45EDGAR2Form 8-K - Current report
07.12.202313:30GLOBEXilio Therapeutics Announces Initiation of Enrollment for..
09.11.202322:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:13EDGAR2Form 8-K - Current report
09.11.202322:10EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
09.11.202322:08EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
09.11.202322:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
09.11.202322:01GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
03.11.202321:05EDGAR2Form 8-K - Current report
03.11.202317:00GLOBEXilio Announces Initial Monotherapy Safety and Anti-Tumor..
31.10.202314:15GLOBEXilio to Host Virtual Investor Conference Call and Webcast..
27.9.202323:02GLOBEXilio Therapeutics Announces Upcoming Presentations at the..
07.9.202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202322:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.9.202314:35EDGAR2Form 8-K - Current report
05.9.202314:30GLOBEXilio Therapeutics Announces Promotion of Katarina..
05.9.202313:30GLOBEXilio Therapeutics to Present at Morgan Stanley 21st Annual..
19.8.202302:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.8.202302:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202313:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202313:40EDGAR2Form 8-K - Current report
14.8.202313:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
07.8.202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.8.202322:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
03.8.202322:15EDGAR2Form 8-K - Current report
03.8.202322:05GLOBEXilio Therapeutics Announces Promotion of Chris Frankenfield..
25.5.202323:01GLOBEXilio Therapeutics Announces Preliminary Clinical Data from..
09.5.202313:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock